Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04952753
Title Study of NIS793 and Other Novel Investigational Combinations With SOC Anti-cancer Therapy for the 2L Treatment of mCRC (daNIS-3)
Acronym daNIS-3
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | ISR | GBR | FRA | ESP | DEU | CZE | CHE | CAN | BEL | AUS

Facility Status City State Zip Country Details
The Angeles Clinic and Research Institute Los Angeles California 90025 United States Details
University of Michigan Medical Ann Arbor Michigan 48109-0331 United States Details
WA Uni School Of Med Saint Louis Missouri 63110 United States Details
Astera Cancer Center East Brunswick New Jersey 08816 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Uni Of TX MD Anderson Cancer Cntr Houston Texas 77030 United States Details
Mays Cancer Center San Antonio Texas 78229 United States Details
Novartis Investigative Site Adelaide South Australia 5000 Australia Details
Novartis Investigative Site Bendigo Victoria 3550 Australia Details
Novartis Investigative Site Perth Western Australia 6009 Australia Details
Novartis Investigative Site Bruxelles 1000 Belgium Details
Novartis Investigative Site Bruxelles 1200 Belgium Details
Novartis Investigative Site Leuven 3000 Belgium Details
Novartis Investigative Site Brampton Ontario L6R 3J7 Canada Details
Novartis Investigative Site Cambridge Ontario N1R 3G2 Canada Details
Novartis Investigative Site Montreal Quebec H2W 1T8 Canada Details
Novartis Investigative Site Montreal Quebec H3T 1E2 Canada Details
Novartis Investigative Site Brno Czech Republic 656 53 Czechia Details
Novartis Investigative Site Hradec Kralove CZE 500 05 Czechia Details
Novartis Investigative Site Praha 4 140 59 Czechia Details
Novartis Investigative Site Avignon 84082 France Details
Novartis Investigative Site Creteil 94010 France Details
Novartis Investigative Site Nantes Cedex 1 44093 France Details
Novartis Investigative Site Berlin 13353 Germany Details
Novartis Investigative Site Bochum 44791 Germany Details
Novartis Investigative Site Dresden 01307 Germany Details
Novartis Investigative Site Essen 45147 Germany Details
Novartis Investigative Site Frankfurt 60488 Germany Details
Novartis Investigative Site Hamburg 20249 Germany Details
Novartis Investigative Site Ulm 89081 Germany Details
Novartis Investigative Site Pokfulam Hong Kong Details
Novartis Investigative Site Shatin HONGKONG Hong Kong Details
Novartis Investigative Site Haifa 3109601 Israel Details
Novartis Investigative Site Petach Tikva 4941492 Israel Details
Novartis Investigative Site Milano MI 20133 Italy Details
Novartis Investigative Site Milano MI 20162 Italy Details
Novartis Investigative Site Rozzano MI 20089 Italy Details
Novartis Investigative Site Nagoya Aichi 464 8681 Japan Details
Novartis Investigative Site Kashiwa Chiba 277 8577 Japan Details
Novartis Investigative Site Kawasaki Kanagawa 216-8511 Japan Details
Novartis Investigative Site Osaka-city Osaka 541-8567 Japan Details
Novartis Investigative Site Toyama 930-0194 Japan Details
Novartis Investigative Site Seoul 05505 Korea, Republic of Details
Novartis Investigative Site Singapore 119074 Singapore Details
Novartis Investigative Site Sabadell Barcelona 08208 Spain Details
Novartis Investigative Site Santander Cantabria 39008 Spain Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site Barcelona Catalunya 08036 Spain Details
Novartis Investigative Site Madrid 28040 Spain Details
Novartis Investigative Site St Gallen 9007 Switzerland Details
Novartis Investigative Site Tainan 70403 Taiwan Details
Novartis Investigative Site Taipei 10002 Taiwan Details
Novartis Investigative Site Aberdeen Grampian Region AB25 2ZN United Kingdom Details
Novartis Investigative Site Cambridge CB2 0QQ United Kingdom Details
Novartis Investigative Site Oxford OX3 7LE United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field